Inventor · disambiguated record
Rudi Bao
Also filed as: BAO RUDI
20 granted patents·16 pending applications·42 citations·filing 2008–2024
92Inventor score
Files withJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD17SHANGHAI HANSOH BIOMEDICAL CO LTD9CURIS INC6CAI XIONG3SHANGHI HANSOH BIOSOH BIOMEDICAL CO LTD1
Top patents by PatentIndex Score
36 records- 0192US8710219B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCAI XIONG·Filed 2012·Granted Apr 29, 2014·14 cites·8 claims
- 0288US9657032B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2015·Granted May 23, 2017·5 cites·21 claims
- 0388US9249156B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2014·Granted Feb 2, 2016·6 cites·9 claims
- 0487US11661437B2Steroid derivative regulators, method for preparing the same, and uses thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted May 30, 2023·3 cites·4 claims
- 0584US8119616B2Formulation of quinazoline based EGFR inhibitors containing a zinc binding moietyCAI XIONG·Filed 2008·Granted Feb 21, 2012·3 cites·54 claims
- 0682US12139508B2Steroid derivative regulators, method for preparing the same, and uses thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Nov 12, 2024·2 cites·3 claims
- 0781US12466823B2Inhibitor containing bicyclic derivative, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Granted Nov 11, 2025·1 cites·18 claims
- 0880US11155534B2EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and applicationJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Oct 26, 2021·1 cites·10 claims
- 0980US10543197B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2018·Granted Jan 28, 2020·1 cites·6 claims
- 1080US8518910B2Formulation of quinazoline based EGFR inhibitors containing a zinc binding moietyCAI XIONG·Filed 2012·Granted Aug 27, 2013·2 cites·26 claims
- 1179US11654136B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2021·Granted May 23, 2023·0 cites·12 claims
- 1279US10759782B2EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and applicationJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Sep 1, 2020·2 cites·4 claims
- 1373US11135205B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2020·Granted Oct 5, 2021·0 cites·18 claims
- 1467US10428081B2EGFR inhibitor, preparation method and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2018·Granted Oct 1, 2019·1 cites·20 claims
- 1567US2025051387A1Steroid derivative regulators, method for preparing the same, and uses thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2024·Application pending·0 cites
- 1666US2022281847A1Egfr inhibitor free base or acid salt polycrystalline form, preparation method therefor, and applicationJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 1763US10259820B2EGFR inhibitor, preparation method and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2015·Granted Apr 16, 2019·1 cites·28 claims
- 1851US2023271969A1Nitrogen-containing fused ring derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2021·Application pending·0 cites
- 1950US2023105212A1Biphenyl derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 2050US2023118497A1Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 2146US2023043863A1Heteroaromatic derivatives for use as regulator, preparation method therefor and use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Application pending·0 cites
- 2246US2022168396A1Multi-receptor agonist and medical use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 2346US2022340547A1Indole derivative-containing inhibitor, preparation method therefor and application thereofSHANGHI HANSOH BIOSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 2443US12497396B2Nitrogen-containing heterocyclic derivatives, method therefor and application therefor as inhibitors of KRAS G12C for the treatment of cancersSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Granted Dec 16, 2025·0 cites·16 claims
- 2543US11472882B2Anti-B7-H4 antibody, antigen-binding fragment thereof and pharmaceutical use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Oct 18, 2022·0 cites·21 claims
- 2643US2013102595A1Treatment of cancers having k-ras mutationsCURIS INC·Filed 2012·Application pending·0 cites
- 2742US2023072897A1Anti-b7-h4 antibody-drug conjugate and medicinal use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 2842US2023076435A1Modifier of four-membered ring derivative, preparation method and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 2941US11608332B2FGFR4 inhibitor and preparation method and use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Mar 21, 2023·0 cites·4 claims
- 3040US2020247815A1Pyrazolyl-containing tricyclic derivative, preparation method therefor and use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2018·Application pending·0 cites
- 3139US11136324B2Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitorsJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Oct 5, 2021·0 cites·18 claims
- 3239US2021355105A1Regulator of nitrogen-containing heteroaromatic derivatives, preparation method therefor and use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Application pending·0 cites
- 3339US2021221822A1Tricyclic derivatives inhibitor, preparation method, and applications thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Application pending·0 cites
- 3437US11667631B2FGFR4 inhibitor, preparation method therefor, and applications thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Jun 6, 2023·0 cites·16 claims
- 3531US2019040025A1Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and applicationJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2017·Application pending·0 cites
- 3628US2018148470A1Cholic acid derivative, and preparation method and medical use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rudi Bao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →